Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

NCT01857622 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

93

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-valvular Atrial Fibrillation

Interventions

DRUG: DU-176b 15mg
DRUG: DU-176b 30mg
DRUG: DU-176b 60mg

Sponsor

Daiichi Sankyo Co., Ltd.